A photochemistry platform that formulates mixtures of edible organic dyes to harness indoor light for generating singlet oxygen that inactivates viruses and bacteria. Dye photobleaching serves as a built-in indicator of photosensitizing activity, enabling self-monitoring sterilization for indoor environments.
This solution leverages edible organic dye mixtures as photosensitizers that absorb indoor visible light to generate singlet oxygen, a reactive species capable of inactivating viruses and bacteria. By tailoring dye combinations to match the specific spectral output of modern indoor lighting (including LEDs and light filtered through coated glass windows), the platform maximizes light harvesting and sterilizing performance in environments where UV irradiation is absent. Photobleaching of the dyes provides a visual, built-in indicator of remaining photosensitizing activity, so users can readily assess when a dye mixture needs replacement.
The approach is at an early research stage. Prior published work has demonstrated that individual edible dyes can photosensitize singlet oxygen and exhibit bactericidal effects under visible light, primarily using sunlight as the irradiation source. The current effort extends this foundation by characterizing modern indoor light spectra and systematically formulating and testing multi-dye mixtures for synergistic performance. Planned validation includes measuring singlet oxygen yields across candidate formulations and benchmarking bactericidal efficacy under representative indoor lighting conditions.
Arizona State University is a comprehensive public research university with a multi-campus presence across the Phoenix metropolitan area and a scale that supports interdisciplinary, use-inspired discovery. Industry partners access co-located laboratories, a research and technology park, and innovation centers that house corporate teams with faculty to speed prototyping and validation. A formal alliance with a major hospital system and proximity to a fast-growing manufacturing corridor enable clinical translation and pilot-scale testbeds, while applied student engagements create dependable talent pipelines. Research is backed by competitive federal funding from agencies such as NSF, NIH, DOE, DOD, and NASA. A dedicated technology transfer office supports IP, licensing, and startup formation.